Injectable Hydrogel Hybrid Material with Covalent Silica Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing biopolymeric hydrogels used as scaffolds for bone tissue reconstruction face challenges such as phase separation and uncontrolled diffusion of particles, lack of bioactivity, and inadequate support for osteoblast cell colonization and mineralization.

Innovation Solution

A biocompatible hydrogel hybrid material is developed by crosslinking a biopolymeric matrix of collagen, chitosan, and hyaluronic acid with silica particles functionalized with amine groups using genipin, forming a covalently bound hybrid material that is injectable and enzymatically degradable.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biopolymeric hydrogels are used as scaffolds for bone tissue reconstruction, then they provide biocompatibility and structural support, but they suffer from phase separation and uncontrolled diffusion of particles

Engineering Contradiction:
Improvestructural stabilityVSAvoidphase separation
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent creates a composite hydrogel system combining biopolymeric matrix (collagen, chitosan, hyaluronic acid) with silica particles functionalized with amine groups. This composite structure integrates two different materials to achieve both biocompatibility and enhanced structural stability, preventing phase separation through covalent bonding between the polymer matrix and silica particles

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent replaces physical mixing or mechanical embedding of silica particles with covalent chemical bonding. The amine-functionalized silica particles form covalent bonds with the biopolymeric matrix during genipin crosslinking, substituting mechanical stabilization with chemical bonding to prevent particle diffusion and phase separation

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If silica particles are dispersed in hydrogel matrix without covalent binding, then they provide bioactivity and mineralization acceleration, but they undergo uncontrolled diffusion to tissues

Engineering Contradiction:
ImprovebioactivityVSAvoiduncontrolled particle diffusion
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces physical dispersion with covalent chemical bonding. Silica particles functionalized with amine groups form covalent bonds with the biopolymeric matrix through genipin crosslinking, substituting mechanical stabilization with chemical bonding to prevent particle diffusion while maintaining bioactivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent applies functionalization only to the surface of silica particles with amine groups, creating a localized reactive interface. This local modification enables covalent bonding at the particle-matrix interface while preserving the bulk properties and bioactivity of the silica particles for mineralization acceleration

Inventive Principle:
Principle #3Local quality

3Ease of operation

If hydrogel material is designed for injectability, then it enables non-invasive introduction into defects, but it requires controlled gelling properties

Engineering Contradiction:
ImproveinjectabilityVSAvoidgelling control
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent utilizes changes in physical parameters (temperature, pH) and chemical parameters (genipin concentration, crosslinking time) to control the gelling process. The hydrogel maintains an injectable sol state under physiological conditions and transitions to a gel state through controlled crosslinking, achieving both injectability and controlled gelling

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent exploits the sol-gel phase transition of the biopolymeric hydrogel. The material is prepared as a soluble injectable form that undergoes phase transition to an insoluble gel network through genipin-induced crosslinking, enabling non-invasive introduction followed by in situ gelation

Inventive Principle:
Principle #36Phase transitions

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hybrid material accelerates mineralization, supports osteoblast cell colonization, maintains biocompatibility, and exhibits bioactivity, while preventing particle diffusion, making it suitable for bone defect reconstruction.

Implementation Method 1

crosslinking through formation of covalent bonds with primary amine groups

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

simultaneous crosslinking, with a biocompatible crosslinking agent, which is genipin, of a biopolymeric hydrogel matrix

Methodology Applied
Scientific EffectCrosslinking:

Implementation Method 3

Surface functionalization with amine groups enabled covalent binding of silica particles with hydrogel polymeric network during crosslinking with genipin

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 4

provides acceleration of mineralization processes

Methodology Applied
Scientific EffectMineralization: Crystallisation

Implementation Method 5

suitable biomatrix for colonization by osteoblast-like cells

Methodology Applied
Scientific EffectBioactivity:

Implementation Method 6

after fulfilling its therapeutic function it will be enzymatically degraded (as was shown) with formation of biocompatible products

Methodology Applied
Scientific EffectEnzymatic degradation: Decomposition (biological)

Data Source

PatentUS12447235B2Hydrogel hybrid material, method of its preparation and application
Publication Date: 2025.10.21 JAGIELLONIAN UNIVERSITY
  • US12447235B2 patent drawing
  • US12447235B2 patent drawing
  • US12447235B2 patent drawing

AI summary

A biocompatible hydrogel hybrid material useful in regenerative medicine, in particular in reconstruction of bone tissue and a method of its preparation is disclosed.